Document is current
Any future updates will be listed below
-
Authors
Kopanz, Julia
Zuidgeest, Mira G. P. https://orcid.org/0000-0003-1463-8243
Rutgrink, Linda
Keighron, Cameron
Grobbee, Diederick E.
Lagerwaard, Bart
,
-
Funding
Funding for this research was provided by:
Innovative Medicines Initiative 2 Joint Undertaking (831458)
- License Information
-
More Information
Article History
Received: 24 October 2025
Accepted: 1 March 2026
First Online: 12 March 2026
Declarations
:
: The RADIAL trial was performed in accordance with the principles of the Declaration of Helsinki, good scientific practice, and the EU General Data Protection Regulation. The trial was submitted in two parts through the Clinical Trials Information System (CTIS) and got authorised (2022–500,449-26-00). In the UK, the trial issued a favourable ethical opinion by both the Health Research Authority and the East of England—Essex Research Ethics Committee (IRAS ID 1006010, REC reference: 22/EE/0184). The trial was registered in the ClinicalTrials.gov database under identifier NCT05780151. All participants signed the informed consent form before trial participation.
: Not applicable.
: LR is an employee of Sanofi and holds shares in this company. The other authors have no conflicts of interest to declare.
